1.
Regional variation limits applications of healthy gut microbiome reference ranges and disease models
by He, Yan
Nature medicine, 2018, Vol.24 (10), p.1532-1535
2.
Understanding the rise of cardiometabolic diseases in low- and middle-income countries
by Miranda, J Jaime
Nature medicine, 2019, Vol.25 (11), p.1667-1679
3.
Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers
by Mars, Nina
Nature medicine, 2020, Vol.26 (4), p.549-557
4.
Mitochondrial Disorders in the Nervous System
by DIMAURO, Salvatore
Annual review of neuroscience, 2008, Vol.31 (1), p.91-123
5.
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic anal...
by Gakidou, Emmanuela
The Lancet (British edition), 2017, Vol.390 (10100), p.1345-1422
6.
Role of Endoplasmic Reticulum Stress in Metabolic Disease and Other Disorders
by Ozcan, Lale
Annual review of medicine, 2012, Vol.63 (1), p.317-328
7.
Contribution of genetics to visceral adiposity and its relation to cardiovascular and metabolic disease
by Karlsson, Torgny
Nature medicine, 2019, Vol.25 (9), p.1390-1395
8.
Metabolically Healthy Obesity and Risk of All-Cause and Cardiovascular Disease Mortality
by Hamer, Mark
The journal of clinical endocrinology and metabolism, 2012, Vol.97 (7), p.2482-2488
9.
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013:...
by Burnett, Richard
The Lancet (British edition), 2015, Vol.386 (10010), p.2287-2323
10.
Trabecular Bone Score (TBS)—A Novel Method to Evaluate Bone Microarchitectural Texture in Patients With Primary Hyperparathyroidism
by Silva, Barbara Campolina
The journal of clinical endocrinology and metabolism, 2013, Vol.98 (5), p.1963-1970
11.
Metabolic bone disease of prematurity: causes, recognition, prevention, treatment and long-term consequences
by Chinoy, Amish
Archives of disease in childhood. Fetal and neonatal edition, 2019, Vol.104 (5), p.F560-F566
12.
Epigenetic mechanisms that underpin metabolic and cardiovascular diseases
by Gluckman, Peter D
Nature reviews. Endocrinology, 2009, Vol.5 (7), p.401-408
13.
Time‐restricted feeding and risk of metabolic disease: a review of human and animal studies
by Rothschild, Jeff
Nutrition reviews, 2014, Vol.72 (5), p.308-318
14.
Use of a Mouse In Vitro Fertilization Model to Understand the Developmental Origins of Health and Disease Hypothesis
by Feuer, Sky K
Endocrinology (Philadelphia), 2014, Vol.155 (5), p.1956-1969
15.
Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with...
by Bernardino, Jose I
The Lancet (British edition), 2015, Vol.2 (11), p.73
16.
Childhood Cardiometabolic Outcomes of Maternal Obesity During Pregnancy The Generation R Study
by Gaillard, Romy
Hypertension (Dallas, Tex. 1979), 2014, Vol.63 (4), p.683-691
17.
Understanding the Physiology of FGF21
by Fisher, Ffolliott Martin
Annual review of physiology, 2016, Vol.78 (1), p.223-241
18.
Sugar consumption, metabolic disease and obesity: The state of the controversy
by Stanhope, Kimber L.
Critical reviews in clinical laboratory sciences, 2016, Vol.53 (1), p.52-67
19.
Contemporary view of the clinical relevance of magnesium homeostasis
by Ayuk, John
Annals of Clinical Biochemistry, 2014, Vol.51 (2), p.179-188
20.
Decreased Circulating Levels of Spexin in Obese Children
by Kumar, Seema
The journal of clinical endocrinology and metabolism, 2016, Vol.101 (7), p.2931-2936
